Literature DB >> 25331728

Posterosuperior lesion has a high risk of lateral and central nodal metastasis in solitary papillary thyroid cancer.

Dong Jin Lee1, Kyu Ho Lee, Jin Hwan Kim, Kee Hwan Kwon, Dae Young Yoon, Young Soo Rho.   

Abstract

BACKGROUND: Preoperative nodal assessment of papillary thyroid cancer (PTC) is very important because 60 to 70 % of all disease recurrence in the neck can occur in the lymph nodes. This study explored the association between ultrasonographic intrathyroidal location and the nodal metastasis pattern in solitary PTC.
METHODS: Data from 218 patients who underwent total thyroidectomy with or without neck dissection for previously untreated PTC between 2006 and 2010 were retrospectively analyzed. Only patient data for which both preoperative ultrasound findings and postoperative pathologic reports were available were included. Multifocal cases, cases with extrathyroidal extension, and distant metastasis were excluded. The association between nodal metastasis pattern and clinical or pathologic features of solitary PTCs was analyzed, as was the association between ultrasonographic intrathyroidal location and central or lateral nodal metastasis in solitary PTC.
RESULTS: Mass size larger than 2 cm (p < 0.001, Odds ratio (OR) 4.117) and central nodal metastasis (p < 0.001, OR 3.984) were related with lateral neck metastasis in multivariate analysis. Male sex (p = 0.001, OR 3.012) and capsular invasion (p < 0.001, OR 4.720) were related with central neck metastasis in multivariate analysis. When analyzing ultrasonographic location of intrathyroidal solitary lesion, posterosuperiorly located lesion was strongly associated with both lateral and central neck metastasis. (p < 0.001 and p = 0.002, respectively).
CONCLUSIONS: Posterosuperior location of intrathyroidal solitary PTC has a high risk of lateral and central nodal metastasis when compared to other locations. For such patients, careful preoperative evaluation of nodal status should be done.

Entities:  

Mesh:

Year:  2015        PMID: 25331728     DOI: 10.1007/s00268-014-2839-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

Review 1.  What is the appropriate extent of lateral neck dissection in the treatment of metastatic well-differentiated thyroid carcinoma?

Authors:  Christian P Hasney; Ronald G Amedee
Journal:  Laryngoscope       Date:  2010-09       Impact factor: 3.325

2.  Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

3.  Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Eun Chang Choi; Yeo-Hoon Yoon; Dong-Hyun Kim; Eung-Hyub Kim; Young Chang Lim
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

4.  An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.

Authors:  Jason P Hunt; Luke O Buchmann; Libo Wang; Dev Abraham
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-11

5.  Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.

Authors:  Qunzi Zhao; Jie Ming; Chunping Liu; Lan Shi; Xia Xu; Xiu Nie; Tao Huang
Journal:  Ann Surg Oncol       Date:  2012-09-13       Impact factor: 5.344

6.  Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer.

Authors:  John C Watkinson; Jayne A Franklyn; Julie F C Olliff
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

7.  Predictors of level V metastasis in well-differentiated thyroid cancer.

Authors:  Michael E Kupferman; Y Etan Weinstock; Alfredo A Santillan; Anupam Mishra; Dianna Roberts; Gary L Clayman; Randal S Weber
Journal:  Head Neck       Date:  2008-11       Impact factor: 3.147

8.  Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Yeo-Hoon Yoon; Jin-Man Kim; Eun Chang Choi; Young Chang Lim
Journal:  Ann Surg Oncol       Date:  2009-02-18       Impact factor: 5.344

9.  Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma.

Authors:  Sang-Hyuk Lee; Seung-Suk Lee; Sung-Min Jin; Jin-Hwan Kim; Young-Soo Rho
Journal:  Laryngoscope       Date:  2008-04       Impact factor: 3.325

10.  Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.

Authors:  Giuseppe Mercante; Andrea Frasoldati; Corrado Pedroni; Debora Formisano; Luigi Renna; Simonetta Piana; Giorgio Gardini; Roberto Valcavi; Verter Barbieri
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

View more
  4 in total

1.  Posterosuperior Lesion has a High Risk of Lateral and Central Nodal Metastasis in Solitary Papillary Thyroid Cancer.

Authors:  Chandan Kumar Jha; Anjali Mishra
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

2.  Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.

Authors:  Daixing Hu; Huapeng Lin; Xuan Zeng; Tielin Wang; Jie Deng; Xinliang Su
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

3.  The association between tumor's location and cervical lymph nodes metastasis in papillary thyroid cancer.

Authors:  Ting-Ting Zhang; Xiu-Zhu Qi; Jian-Ping Chen; Rong-Liang Shi; Shi-Shuai Wen; Yu-Long Wang; Qing-Hai Ji; Qiang Shen; Yong-Xue Zhu; Ning Qu
Journal:  Gland Surg       Date:  2019-10

4.  Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma.

Authors:  Daixing Hu; Jing Zhou; Wei He; Jie Peng; Yijia Cao; Haoyu Ren; Yu Mao; Yi Dou; Wei Xiong; Qi Xiao; Xinliang Su
Journal:  World J Surg Oncol       Date:  2018-02-13       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.